Basic Information
Basic information for SNHG14-259-16aa-2
Peptide Name SNHG14-259-16aa-2
Genome Position chr15:25419156-25419203[+]
Species Human
Peptide Sequence MYYTAINNWNSIVNSS
Peptide Length 16
Unique No (SNHG14-203-16aa,SNHG14-219-16aa,SNHG14-221-16aa,SNHG14-226-16aa,SNHG14-228-16aa,SNHG14-229-16aa,SNHG14-233-16aa-1,SNHG14-243-16aa,SNHG14-244-16aa,SNHG14-245-16aa,SNHG14-247-16aa-2,SNHG14-252-16aa,SNHG14-260-16aa-3,SNHG14-262-16aa-2,SNHG14-266-16aa,SNHG14-267-16aa,SNHG14-284-16aa,SNHG14-285-16aa,SNHG14-286-16aa-2,SNHG14-292-16aa,SNHG14-294-16aa,SNHG14-295-16aa,SNHG14-296-16aa-2,SNHG14-306-16aa,SNHG14-317-16aa-2,SNHG14-320-16aa,SNHG14-326-16aa-2,SNHG14-328-16aa,SNHG14-329-16aa,SNHG14-331-16aa-2)
Grand Average of Hydropathicity -0.2312
Relative Molecular Mass 2147.3
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000658502;SNHG14-259
Transcript Length 2094
Coding Ability 0.352
DNA Sequence Corresponding to Peptide ATGTATTACACAGCAATAAATAACTGGAACAGCATAGTAAATTCTAGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :